Cargando…

Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet

Qianbai biyan tablet (QT) is a compound prescription of traditional Chinese medicine which is used to treat nasal congestion, rhinitis, and nasosinusitis, with Senecio scandens as its main plant material. Several pyrrolizidine alkaloids (PAs) were reported in Senecio scandens and others of Senecio s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mengting, Tan, Daopeng, Lu, Anjing, Qin, Lin, Wang, Changhong, Ling, Hua, Lu, Yanliu, He, Yuqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445730/
https://www.ncbi.nlm.nih.gov/pubmed/34539789
http://dx.doi.org/10.1155/2021/5209618
_version_ 1784568712328642560
author Yang, Mengting
Tan, Daopeng
Lu, Anjing
Qin, Lin
Wang, Changhong
Ling, Hua
Lu, Yanliu
He, Yuqi
author_facet Yang, Mengting
Tan, Daopeng
Lu, Anjing
Qin, Lin
Wang, Changhong
Ling, Hua
Lu, Yanliu
He, Yuqi
author_sort Yang, Mengting
collection PubMed
description Qianbai biyan tablet (QT) is a compound prescription of traditional Chinese medicine which is used to treat nasal congestion, rhinitis, and nasosinusitis, with Senecio scandens as its main plant material. Several pyrrolizidine alkaloids (PAs) were reported in Senecio scandens and others of Senecio species. Although Senecio scandens is assigned as the legal plant material of QT, whether replaced use of it by other Senecio plants can bring toxicity is unknown because of the lack of quantitative data about toxic PAs between different Senecio species. In the present study, adonifoline, senkirkine, and another PA presumed as emiline have been identified in QT; however, there was no senecionine detected in all tablets. PA contents in QTs varied in different companies and different batches. Adonifoline existed only in Senecio scandens, and senecionine was detected in all eight Senecio plants investigated in the present study. Data showed that replaced use of Senecio scandens with a low level of senecionine by other Senecio plants such as Senecio vulgaris containing a high level of senecionine is advertised to be forbidden. Data of the present study may be used as a reference to make new drug quality regularity and recommendation guideline for the safety of QT.
format Online
Article
Text
id pubmed-8445730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84457302021-09-17 Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet Yang, Mengting Tan, Daopeng Lu, Anjing Qin, Lin Wang, Changhong Ling, Hua Lu, Yanliu He, Yuqi Int J Anal Chem Research Article Qianbai biyan tablet (QT) is a compound prescription of traditional Chinese medicine which is used to treat nasal congestion, rhinitis, and nasosinusitis, with Senecio scandens as its main plant material. Several pyrrolizidine alkaloids (PAs) were reported in Senecio scandens and others of Senecio species. Although Senecio scandens is assigned as the legal plant material of QT, whether replaced use of it by other Senecio plants can bring toxicity is unknown because of the lack of quantitative data about toxic PAs between different Senecio species. In the present study, adonifoline, senkirkine, and another PA presumed as emiline have been identified in QT; however, there was no senecionine detected in all tablets. PA contents in QTs varied in different companies and different batches. Adonifoline existed only in Senecio scandens, and senecionine was detected in all eight Senecio plants investigated in the present study. Data showed that replaced use of Senecio scandens with a low level of senecionine by other Senecio plants such as Senecio vulgaris containing a high level of senecionine is advertised to be forbidden. Data of the present study may be used as a reference to make new drug quality regularity and recommendation guideline for the safety of QT. Hindawi 2021-09-09 /pmc/articles/PMC8445730/ /pubmed/34539789 http://dx.doi.org/10.1155/2021/5209618 Text en Copyright © 2021 Mengting Yang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yang, Mengting
Tan, Daopeng
Lu, Anjing
Qin, Lin
Wang, Changhong
Ling, Hua
Lu, Yanliu
He, Yuqi
Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
title Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
title_full Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
title_fullStr Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
title_full_unstemmed Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
title_short Identification and Simultaneous Determination of the Main Toxical Pyrrolizidine Alkaloids in a Compound Prescription of Traditional Chinese Medicine: Qianbai Biyan Tablet
title_sort identification and simultaneous determination of the main toxical pyrrolizidine alkaloids in a compound prescription of traditional chinese medicine: qianbai biyan tablet
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445730/
https://www.ncbi.nlm.nih.gov/pubmed/34539789
http://dx.doi.org/10.1155/2021/5209618
work_keys_str_mv AT yangmengting identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT tandaopeng identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT luanjing identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT qinlin identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT wangchanghong identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT linghua identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT luyanliu identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet
AT heyuqi identificationandsimultaneousdeterminationofthemaintoxicalpyrrolizidinealkaloidsinacompoundprescriptionoftraditionalchinesemedicineqianbaibiyantablet